White Paper
Clinical Development
Life Sciences
Clinical data
The value of tokenizing clinical development data for real-world evidence-based use cases
There is an ever-present need to accelerate clinical development to ensure that therapies and devices can reach patients as quickly as possible. Real-word data (RWD) offers the opportunity to focus on the needs of patients while reducing unnecessary spend if used correctly. However, there are existing challenges to overcome to realize the benefit.
Related Documents
Datasheet
Zelta Data Integration
Your Trials. Your Choice.
eBook
Driving the speed of adoption with decentralized clinical trials
The evolution of clinical research throughout the pandemic, and beyond
Solution Brief
Zelta: A clinical trials platform
With the Zelta clinical trials platform, you are in full command of every aspect of your clinical trials and research. We empower you to take control in every stage and our ...